Hou M - Search Results

1

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.

Wu YL, Sequist LV, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Schuler M, Mok T, Yamamoto N, O'Byrne K, Hirsh V, Gibson N, Massey D, Kim M, Yang JC. Wu YL, et al. Among authors: hou m. Br J Cancer. 2017 Jan 17;116(2):175-185. doi: 10.1038/bjc.2016.420. Epub 2016 Dec 22. Br J Cancer. 2017. PMID: 28006816 Free PMC article. Clinical Trial.

2

Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.

Gong Y, Ren L, Zhou L, Zhu J, Huang M, Zhou X, Wang J, Lu Y, Hou M, Wei Y. Gong Y, et al. Among authors: hou m. Cancer Chemother Pharmacol. 2009 Jul;64(2):327-33. doi: 10.1007/s00280-008-0874-8. Epub 2008 Dec 2. Cancer Chemother Pharmacol. 2009. PMID: 19048253 Clinical Trial.

3

[A randomized study of gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin as the 1st line chemotherapy for advanced non-small cell lung cancer in elderly patients].

Li Z, Hou M, Wang H, Wang Z. Li Z, et al. Among authors: hou m. Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):588-92. doi: 10.3779/j.issn.1009-3419.2011.07.05. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21762628 Free PMC article. Clinical Trial. Chinese.

4

[Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancer using bi-loop probe specific primer quantitative PCR].

Wang LS, Zhang Y, Lu XJ, Lu HJ, Zhou L, Wang YS, Deng L, Huang MJ, Peng F, Wang J, Ren L, Hou M, Li L, Xu Y, Ying BW, Lu Y. Wang LS, et al. Among authors: hou m. Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):667-70. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 22321544 Chinese.

5

[A randomized clinical trial on the clinical efficacy and toxicities of single-agent paclitaxel liposome versus paclitaxel liposome plus oxaliplatin as first-line chemotherapy for advanced non-small cell lung cancer in elderly patients].

Zeng X, Li Z, Hou M. Zeng X, et al. Among authors: hou m. Zhongguo Fei Ai Za Zhi. 2012 Feb;15(2):84-9. doi: 10.3779/j.issn.1009-3419.2012.02.04. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22336235 Free PMC article. Clinical Trial. Chinese.

6

[A randomized controlled study of chemotherapy: etoposide combined with oxaliplatin or cisplatin regimens in the treatment of extensive-stage small cell lung cancer in elderly patients].

Pu D, Hou M, Li Z, Zeng X. Pu D, et al. Among authors: hou m. Zhongguo Fei Ai Za Zhi. 2013 Jan;16(1):20-4. doi: 10.3779/j.issn.1009-3419.2013.01.04. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23327869 Free PMC article. Clinical Trial. Chinese.

7

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.

Wu YL, Zhou C, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Lee KY, Xu CR, Massey D, Kim M, Shi Y, Geater SL. Wu YL, et al. Among authors: hou m. Lancet Oncol. 2014 Feb;15(2):213-22. doi: 10.1016/S1470-2045(13)70604-1. Epub 2014 Jan 15. Lancet Oncol. 2014. PMID: 24439929 Clinical Trial.

8

[Fourth-line and beyond therapy in advanced non-small cell lung cancer: a retrospective analysis].

Wang X, Huang M, Ren L, Xu Y, Li L, Hou M, Wang J, Peng F, Zhu J, Wang Y, Lu Y. Wang X, et al. Among authors: hou m. Zhongguo Fei Ai Za Zhi. 2014 Dec;17(12):839-44. doi: 10.3779/j.issn.1009-3419.2014.12.03. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25539608 Free PMC article. Chinese.

9

Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer.

Geater SL, Xu CR, Zhou C, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Lee KY, Palmer M, Shi Y, Lungershausen J, Wu YL. Geater SL, et al. Among authors: hou m. J Thorac Oncol. 2015 Jun;10(6):883-9. doi: 10.1097/JTO.0000000000000517. J Thorac Oncol. 2015. PMID: 25933111 Free article. Clinical Trial.

10

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.

Sun Y, Cheng Y, Hao X, Wang J, Hu C, Han B, Liu X, Zhang L, Wan H, Xia Z, Liu Y, Li W, Hou M, Zhang H, Xiu Q, Zhu Y, Feng J, Qin S, Luo X. Sun Y, et al. Among authors: hou m. BMC Cancer. 2016 Apr 9;16:265. doi: 10.1186/s12885-016-2301-6. BMC Cancer. 2016. PMID: 27061082 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,739 results

Search Page

Filters